Discover Q2 2025 insights on ICON Public Limited Company (ICLR), featuring revenue growth, digital innovation, biotech partnerships, and cautious ...

ICON Public Limited Company is still off its highs and has some absolute valuation appeal. Click here to see why ICLR stock ...

Roche gained 0.8% after the Swiss drugmaker reported better-than-expected first-half operating profit, while Deutsche Telekom ...

Evercore ISI raised the firm’s price target on Icon (ICLR) to $240 from $170 and keeps an Outperform rating on the shares. The company provided a ...